Literature DB >> 6331929

Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS.

M Cavaille-Coll, A Messiah, D Klatzmann, W Rozenbaum, D Lachiver, S Kernbaum, E Brisson, F Chapuis, C Blanc, P Debre.   

Abstract

In order to determine whether there exists a distinct immunological profile that discriminates between healthy homosexual men and those expressing persistent generalized hyperplastic lympadenopathy GHL and which of the observed abnormalities in GHL would be most indicative of patients who would eventually develop AIDS, we evaluated T lymphocyte subset and in vitro proliferative responses. The respective profiles of 44 symptom free homosexual men (HC), 42 patients with GHL and 30 cases of AIDS were compared to that of blood bank volunteers (BBV) and to each other, using stepwise discrimination analysis. HC, GHL and AIDS patients demonstrated upon their first investigation varying degrees of the same type of abnormal immunological characteristics. The percentage of OKT4+ cells was the most discriminant variable between BBV and HC, GHL or AIDS. GHL was distinguished from HC primarily by a higher percentage of OKT8+ cells and from AIDS by higher T lymphocyte counts, while the OKT4+ cell count discriminated between AIDS and HC. However, none of these major discriminant variables could classify correctly more than 71% within the HC and the two patient groups. Thus, there exists a continuity between GHL and AIDS in the range of observed immunological abnormalities without clearcut boundaries. This, together with the existence of abnormal background values in HC will not permit a single investigation of T lymphocyte immune parameters to provide substantial diagnostic and prognostic evidence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331929      PMCID: PMC1536264     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  T-cell ratios in homosexuals.

Authors:  J I Wallace; F S Coral; I R Rimm; H Lane; H Levine; E L Reinherz; S F Schlossman; J Sonnabend
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

2.  T-lymphocyte subpopulations in homosexual men.

Authors:  H Kornfeld; R A Vande Stouwe; M Lange; M M Reddy; M H Grieco
Journal:  N Engl J Med       Date:  1982-09-16       Impact factor: 91.245

Review 3.  Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings.

Authors:  E L Reinherz; S F Schlossman
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

4.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.

Authors:  H Masur; M A Michelis; J B Greene; I Onorato; R A Stouwe; R S Holzman; G Wormser; L Brettman; M Lange; H W Murray; S Cunningham-Rundles
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

5.  The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies.

Authors:  E L Reinherz; C O'Brien; P Rosenthal; S F Schlossman
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

6.  Disseminated Kaposi's sarcoma in homosexual men.

Authors:  A E Friedman-Kien; L J Laubenstein; P Rubinstein; E Buimovici-Klein; M Marmor; R Stahl; I Spigland; K S Kim; S Zolla-Pazner
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Opportunistic infections and immune deficiency in homosexual men.

Authors:  D Mildvan; U Mathur; R W Enlow; P L Romain; R J Winchester; C Colp; H Singman; B R Adelsberg; I Spigland
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

8.  The effect of infection on T lymphocyte subpopulations: a preliminary report.

Authors:  R H Rubin; W P Carney; R T Schooley; R B Colvin; R C Burton; R A Hoffman; W P Hansen; A B Cosimi; P S Russell; M S Hirsch
Journal:  Int J Immunopharmacol       Date:  1981

9.  Suppression of lymphocyte reactivity by blood transfusions in uremic patients. I. Proliferative responses.

Authors:  D Klatzmann; J C Gluckman; C Foucault; A Bensussan; U Assobga; A Duboust
Journal:  Transplantation       Date:  1983-04       Impact factor: 4.939

10.  Prevalence of cytomegalovirus infection in homosexual men.

Authors:  W L Drew; L Mintz; R C Miner; M Sands; B Ketterer
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

View more
  9 in total

1.  Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects.

Authors:  F Vuillier; C Lapresle; G Dighiero
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

2.  Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?

Authors:  M M Chan; J M Campos; S Josephs; N Rifai
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

3.  The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.

Authors:  W J Boyko; M T Schechter; E Jeffries; B Douglas; M Maynard; M O'Shaughnessy
Journal:  Can Med Assoc J       Date:  1985-07-01       Impact factor: 8.262

4.  Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.

Authors:  F Vuillier; D Scott-Algara; P Tortevoye; G Pialoux; G Dighiero
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

5.  Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.

Authors:  L O Arthur; S W Pyle; P L Nara; J W Bess; M A Gonda; J C Kelliher; R V Gilden; W G Robey; D P Bolognesi; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  Diagnostic utility of lymphocyte subset analysis in AIDS case finding.

Authors:  W J Boyko; M T Schechter; A MacLeod; B Douglas; M Maynard; R Sharp; B Wiggs
Journal:  CMAJ       Date:  1986-05-01       Impact factor: 8.262

7.  The Vancouver Lymphadenopathy-AIDS Study: 5. Antecedent behavioural, clinical and laboratory findings in patients with AIDS and HIV-seropositive controls.

Authors:  W J Boyko; M T Schechter; K J Craib; P Constance; R Nitz; S Fay; A McLeod; M O'Shaughnessy
Journal:  CMAJ       Date:  1986-10-15       Impact factor: 8.262

8.  Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?

Authors:  J C Gluckman; D Klatzmann; M Cavaille-Coll; E Brisson; A Messiah; D Lachiver; W Rozenbaum
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

9.  Defective T-cell differentiation in acquired immune deficiency syndrome (AIDS).

Authors:  E M Levy; J C Beldekas; K H Mayer; P H Black
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.